Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Thomas Ring

Orthopaedic Surgery Baltimore, MD Medical Doctor

NPI 1689870214 CMS profile 212697

3333 N Calvert St Ste 101, Baltimore, MD 21218

Open in the dashboard

General payments

$3,023

27 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thomas Ring of Baltimore, MD is reported in the CMS Open Payments database as having received $3,023 across 27 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 46th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,112 10
2024 General $116 1
2020 General $45 1
2019 General $1,750 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Ring
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Thomas Ring were reported at $1,112. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Thomas Ring Orthopaedic Surgery median Middle half National median
2019 $1,750 $644 $140–$2,844 $163
2020 $45 $312 $75–$1,860 $114
2021 $0 $520 $117–$2,495 $132
2022 $0 $598 $128–$2,731 $149
2023 $0 $461 $128–$2,264 $160
2024 $116 $497 $134–$2,475 $164
2025 $1,112 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $1,777 15 payments
  2. Zimmer Biomet Holdings, Inc. $1,170 9 payments
  3. OrthoSensor Inc. $35 1 payment
  4. DePuy Synthes Sales Inc. $28 1 payment
  5. Smith+Nephew, Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $1,973 10 payments
  2. Food and Beverage $1,050 17 payments
Products named General payments · program years 2019–2025
  1. Arcos $908 7 payments
  2. MAKO $661 5 payments
  3. Persona $262 2 payments
  4. NEW PRODUCT DEVELOPMENT $150 1 payment
  5. SYSTEM 9 CD NXT $82 1 payment
  6. Verasense $35 1 payment
  7. CORAIL $28 1 payment
  8. T7 $18 1 payment
  9. ZIPSEAL 24 SURGICAL SKIN CLOSURE KIT $13 1 payment
  10. PICO 7 Single Use Negative Pressure Wound Therapy $13 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

152

Median for Orthopedic Surgery: 203

Drug cost

$521

Median for Orthopedic Surgery: $1,433

Branded share of claims

13.8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 34 $181
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 21 $133
Cephalexin Generic 23 $84
Tramadol Hcl Generic 27 $57
Amoxicillin Generic 35 $40
Meloxicam Generic 12 $27

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$228,346

Of which drugs: $13,044

Medicare patients

459

Average age 74

Services billed

2,723

311 women, 148 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 32%
Ischemic heart disease 24%
Depression 24%
Chronic kidney disease 22%
Cancer 18%
Osteoporosis 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose J7326 Office 20 25 $10,077
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 99 692 $481
Injection, ketorolac tromethamine, per 15 mg J1885 Office 50 176 $84

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

27 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record